Raptor Pharmaceutical Corp Financial and Nonfinancial Liabilities, Fair Value Disclosure
Raptor Pharmaceutical Corp had Financial and Nonfinancial Liabilities, Fair Value Disclosure of $13.47 million as of 2013-06-30, per its 10-Q/A filed 2014-05-12.
Discontinued › Notes › Fair Value Measures and Disclosures › Fair Value Disclosures › Fair Value, Net Asset (Liability)
us-gaap:LiabilitiesFairValueDisclosure · last filed 2014-05-12
- 2013-06-30: Financial and Nonfinancial Liabilities, Fair Value Disclosure $13.47M.
- 2012-12-31: Financial and Nonfinancial Liabilities, Fair Value Disclosure $16.41M.
| Period end | Financial and Nonfinancial Liabilities, Fair Value Disclosure |
|---|---|
| 2013-06-30 | $13.47M 10-Q/A · filed 2014-05-12 |
| 2012-12-31 | $16.41M 10-Q/A · filed 2014-05-12 |